In conclusion, the observed reduction in the KYN/TRP ratio is likely indicative of a combination of treatment-induced enzyme suppression, glucocorticoid receptor resistance in chronic disease, and anti-inflammatory conditions—factors that overshadow the transient effects of TRP depletion in major depressive disorder. The gene discussed is NR3C1; the disease is major depressive disorder.